| Literature DB >> 27300676 |
Sumit Gupta1, Joanne F Aitken2, Ute Bartels3, James Brierley4, Mae Dolendo5, Paola Friedrich6, Soad Fuentes-Alabi7, Claudia P Garrido8, Gemma Gatta9, Mary Gospodarowicz4, Thomas Gross10, Scott C Howard11, Elizabeth Molyneux12, Florencia Moreno13, Jason D Pole14, Kathy Pritchard-Jones15, Oscar Ramirez16, Lynn A G Ries17, Carlos Rodriguez-Galindo6, Hee Young Shin18, Eva Steliarova-Foucher19, Lillian Sung3, Eddy Supriyadi20, Rajaraman Swaminathan21, Julie Torode22, Tushar Vora23, Tezer Kutluk22, A Lindsay Frazier6.
Abstract
Population-based cancer registries generate estimates of incidence and survival that are essential for cancer surveillance, research, and control strategies. Although data on cancer stage allow meaningful assessments of changes in cancer incidence and outcomes, stage is not recorded by most population-based cancer registries. The main method of staging adult cancers is the TNM classification. The criteria for staging paediatric cancers, however, vary by diagnosis, have evolved over time, and sometimes vary by cooperative trial group. Consistency in the collection of staging data has therefore been challenging for population-based cancer registries. We assembled key experts and stakeholders (oncologists, cancer registrars, epidemiologists) and used a modified Delphi approach to establish principles for paediatric cancer stage collection. In this Review, we make recommendations on which staging systems should be adopted by population-based cancer registries for the major childhood cancers, including adaptations for low-income countries. Wide adoption of these guidelines in registries will ease international comparative incidence and outcome studies.Entities:
Mesh:
Year: 2016 PMID: 27300676 DOI: 10.1016/S1470-2045(15)00539-2
Source DB: PubMed Journal: Lancet Oncol ISSN: 1470-2045 Impact factor: 41.316